Advisory Board March 25, 2024

CMS on Thursday announced that Medicare Part D drug benefit plans can cover weight-loss drugs for patients who have a history of heart disease and are using the drugs to prevent heart attacks and strokes.

Related: Wegovy’s benefits are real, but access remains an issue

Medicare will cover certain weight-loss drugs

Currently, federal law prevents Medicare Part D plans from covering obesity medications for weight loss alone. However, CMS’ new guidance states that Medicare Part D plans can cover anti-obesity medications provided the drugs receive approval for “an additional medically accepted indication.”

“For example, a drug that receives FDA approval for chronic weight management alone would not be considered a Part D drug,” CMS said. “[But] if this same drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma / Biotech, Provider
Innovation — but at what price? CMMI Under the Microscope
What’s Behind Slow Uptake of Rural Emergency Hospital Designation?
Improving Access To Medigap When Beneficiaries Leave Medicare Advantage
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B
GOP jumps on chance to bash Biden on Medicare

Share This Article